[go: up one dir, main page]

NO875136D0 - Heste - gamma - interferon. - Google Patents

Heste - gamma - interferon.

Info

Publication number
NO875136D0
NO875136D0 NO875136A NO875136A NO875136D0 NO 875136 D0 NO875136 D0 NO 875136D0 NO 875136 A NO875136 A NO 875136A NO 875136 A NO875136 A NO 875136A NO 875136 D0 NO875136 D0 NO 875136D0
Authority
NO
Norway
Prior art keywords
gamma
eqifn
interferon
horses
polypeptide
Prior art date
Application number
NO875136A
Other languages
English (en)
Other versions
NO180239C (no
NO180239B (no
NO875136L (no
Inventor
Rudolf Hauptmann
Adolf Himmler
Peter Swetly
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO875136D0 publication Critical patent/NO875136D0/no
Publication of NO875136L publication Critical patent/NO875136L/no
Publication of NO180239B publication Critical patent/NO180239B/no
Publication of NO180239C publication Critical patent/NO180239C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO875136A 1986-12-10 1987-12-09 Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid NO180239C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863642096 DE3642096A1 (de) 1986-12-10 1986-12-10 Pferde-(gamma)-interferon

Publications (4)

Publication Number Publication Date
NO875136D0 true NO875136D0 (no) 1987-12-09
NO875136L NO875136L (no) 1988-06-13
NO180239B NO180239B (no) 1996-12-02
NO180239C NO180239C (no) 1997-03-12

Family

ID=6315829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875136A NO180239C (no) 1986-12-10 1987-12-09 Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid

Country Status (20)

Country Link
US (1) US5602010A (no)
EP (1) EP0271824B1 (no)
JP (3) JPS63233794A (no)
KR (1) KR880007568A (no)
AT (1) ATE91722T1 (no)
AU (1) AU616873B2 (no)
CA (1) CA1339776C (no)
DE (2) DE3642096A1 (no)
DK (1) DK170054B1 (no)
ES (1) ES2058094T3 (no)
FI (1) FI99116C (no)
HU (1) HU213566B (no)
IE (1) IE60404B1 (no)
IL (1) IL84780A (no)
NO (1) NO180239C (no)
NZ (1) NZ222856A (no)
PH (1) PH30889A (no)
PT (1) PT86332B (no)
SU (1) SU1701114A3 (no)
ZA (1) ZA879245B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU564690B2 (en) 1980-04-03 1987-08-20 Biogen Idec Ma Inc. Process for producing human fibroblast interferon-like polypeptides using recombinant dna
US5272263A (en) 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
GB2291645A (en) * 1994-07-21 1996-01-31 Q One Biotech Ltd Equine gamma-interferon
GB9414752D0 (en) * 1994-07-21 1994-09-07 Q One Biotech Ltd Feline gamma-interferon
AU2002225870B2 (en) * 2000-11-03 2006-09-21 Intarcia Therapeutics, Inc. Method for short-term and long-term drug dosimetry
US20030143197A1 (en) * 2001-11-09 2003-07-31 Moran S. Mark Method for treating diseases with omega interferon
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2007140416A2 (en) 2006-05-30 2007-12-06 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
JP5048773B2 (ja) 2006-08-09 2012-10-17 インターシア セラピューティクス，インコーポレイティド 浸透圧式デリバリーシステム及びピストンアセンブリー
NZ580447A (en) 2007-04-23 2011-06-30 Intarcia Therapeutics Inc Suspension formulations of insulinotropic peptides and uses thereof
CA2726861C (en) 2008-02-13 2014-05-27 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
RU2753280C2 (ru) 2009-09-28 2021-08-12 Интарсия Терапьютикс, Инк. Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
CN109310743A (zh) 2016-05-16 2019-02-05 因塔西亚制药公司 胰高血糖素受体选择性多肽及其使用方法
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
MX2019008006A (es) 2017-01-03 2019-08-29 Intarcia Therapeutics Inc Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE88622C (no) *
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) * 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) * 1985-10-07 1987-08-25 Neogen Corporation Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity

Also Published As

Publication number Publication date
NZ222856A (en) 1991-11-26
DK645887A (da) 1988-06-11
EP0271824B1 (de) 1993-07-21
ZA879245B (en) 1989-08-30
DE3642096A1 (de) 1988-06-16
US5602010A (en) 1997-02-11
JPH07250690A (ja) 1995-10-03
ES2058094T3 (es) 1994-11-01
EP0271824A3 (en) 1989-05-24
EP0271824A2 (de) 1988-06-22
NO180239C (no) 1997-03-12
DK645887D0 (da) 1987-12-09
SU1701114A3 (ru) 1991-12-23
NO180239B (no) 1996-12-02
IE873342L (en) 1988-06-10
ATE91722T1 (de) 1993-08-15
AU8223387A (en) 1988-06-30
HUT46066A (en) 1988-09-28
AU616873B2 (en) 1991-11-14
FI99116B (fi) 1997-06-30
IL84780A (en) 1992-11-15
CA1339776C (en) 1998-03-24
HU213566B (en) 1997-08-28
FI875427A0 (fi) 1987-12-10
JPS63233794A (ja) 1988-09-29
KR880007568A (ko) 1988-08-27
NO875136L (no) 1988-06-13
PH30889A (en) 1997-12-23
DK170054B1 (da) 1995-05-08
FI99116C (fi) 1997-10-10
IE60404B1 (en) 1994-07-13
DE3786649D1 (de) 1993-08-26
JPH07258294A (ja) 1995-10-09
IL84780A0 (en) 1988-05-31
FI875427L (fi) 1988-06-11
PT86332B (pt) 1990-11-07
PT86332A (de) 1988-01-01

Similar Documents

Publication Publication Date Title
ATE91722T1 (de) Pferde-gamma-interferon.
DZ467A1 (fr) Interferon immunitaire urbain.
DK638887A (da) Syntetiske polypeptider og deres anvendelse til diagnosticering
NO863000L (no) Fusjonsproteiner og fremgangsmaate til fremstilling derav.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DK491487A (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
ATE109205T1 (de) Verbesserung der ausbeute bei der sekretion von disulfidverbrückten proteinen.
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB2171703B (en) Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
NO178704C (no) DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet